New Science from AHA Scientific Sessions 2022 - CVD Risk Management in Patients with T2D

This podcast highlights the new science presented at the American Heart Association's (AHA's) Scientific Sessions in 2022. Jane Reusch, MD, Nathan Wong, PhD, MPH, and Chiadi Ndumele, MD, PhD, MHS discuss clinical highlights related to CVD risk management in patients with diabetes, including renal disease, and how to incorporate these findings into clinical practice.